Your browser doesn't support javascript.
A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
Resende, Paola Cristina; Gräf, Tiago; Paixão, Anna Carolina Dias; Appolinario, Luciana; Lopes, Renata Serrano; Mendonça, Ana Carolina da Fonseca; da Rocha, Alice Sampaio Barreto; Motta, Fernando Couto; Neto, Lidio Gonçalves Lima; Khouri, Ricardo; de Oliveira, Camila I; Santos-Muccillo, Pedro; Bezerra, João Felipe; Teixeira, Dalane Loudal Florentino; Riediger, Irina; Debur, Maria do Carmo; Ribeiro-Rodrigues, Rodrigo; Leite, Anderson Brandao; do Santos, Cliomar Alves; Gregianini, Tatiana Schäffer; Fernandes, Sandra Bianchini; Bernardes, André Felipe Leal; Cavalcanti, Andrea Cony; Miyajima, Fábio; Sachhi, Claudio; Mattos, Tirza; da Costa, Cristiano Fernandes; Delatorre, Edson; Wallau, Gabriel L; Naveca, Felipe G; Bello, Gonzalo; Siqueira, Marilda Mendonça.
  • Resende PC; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Gräf T; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • Paixão ACD; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Appolinario L; Plataforma de Vigilância Molecular, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Lopes RS; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Mendonça ACDF; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • da Rocha ASB; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Motta FC; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • Neto LGL; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Khouri R; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • de Oliveira CI; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Santos-Muccillo P; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • Bezerra JF; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Teixeira DLF; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • Riediger I; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Debur MDC; Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
  • Ribeiro-Rodrigues R; Laboratório Central de Saúde Pública do Estado do Maranhão (LACEN-MA), São Luís 65020-904, Brazil.
  • Leite AB; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • do Santos CA; Plataforma de Vigilância Molecular, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Gregianini TS; Laboratório de Enfermidades Infecciosas Transmitidas por Vetores, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Fernandes SB; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Bernardes AFL; Plataforma de Vigilância Molecular, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Cavalcanti AC; Laboratório de Enfermidades Infecciosas Transmitidas por Vetores, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Miyajima F; Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
  • Sachhi C; Plataforma de Vigilância Molecular, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • Mattos T; Laboratório de Patologia e Biologia Molecular, Instituto Gonçalo Moniz, Fiocruz-BA, Salvador 40296-710, Brazil.
  • da Costa CF; Laboratório de Vigilância Molecular Aplicada, Escola Técnica de Saúde, Centro de Ciências da Saúde, Universidade Federal da Paraíba, (UFPB), João Pessoa 58051-900, Brazil.
  • Delatorre E; Laboratório Central de Saúde Pública do Estado da Paraíba (LACEN-PB), João Pessoa 58013-360, Brazil.
  • Wallau GL; Laboratório Central de Saúde Pública do Estado do Paraná (LACEN-PR), São José dos Pinhais 83060-500, Brazil.
  • Naveca FG; Laboratório Central de Saúde Pública do Estado do Paraná (LACEN-PR), São José dos Pinhais 83060-500, Brazil.
  • Bello G; Laboratório Central de Saúde Pública do Estado do Espírito Santo (LACEN-ES), Vitoria 29050-755, Brazil.
  • Siqueira MM; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitoria 29050-625, Brazil.
Viruses ; 13(5)2021 04 21.
Article in English | MEDLINE | ID: covidwho-1202040
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Brazil was dominated by two lineages designated as B.1.1.28 and B.1.1.33. The two SARS-CoV-2 variants harboring mutations at the receptor-binding domain of the Spike (S) protein, designated as lineages P.1 and P.2, evolved from lineage B.1.1.28 and are rapidly spreading in Brazil. Lineage P.1 is considered a Variant of Concern (VOC) because of the presence of multiple mutations in the S protein (including K417T, E484K, N501Y), while lineage P.2 only harbors mutation SE484K and is considered a Variant of Interest (VOI). On the other hand, epidemiologically relevant B.1.1.33 deriving lineages have not been described so far. Here we report the identification of a new SARS-CoV-2 VOI within lineage B.1.1.33 that also harbors mutation SE484K and was detected in Brazil between November 2020 and February 2021. This VOI displayed four non-synonymous lineage-defining mutations (NSP3A1711V, NSP6F36L, SE484K, and NS7bE33A) and was designated as lineage N.9. The VOI N.9 probably emerged in August 2020 and has spread across different Brazilian states from the Southeast, South, North, and Northeast regions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Mutation Type of study: Observational study Topics: Variants Limits: Humans Country/Region as subject: South America / Brazil Language: English Year: 2021 Document Type: Article Affiliation country: V13050724

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Mutation Type of study: Observational study Topics: Variants Limits: Humans Country/Region as subject: South America / Brazil Language: English Year: 2021 Document Type: Article Affiliation country: V13050724